Clinical Trial: Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis

U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07890415) titled 'Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis' on Oct. 16.

Brief Summary: The purpose of this study is to learn whether a computer-based support tool called DEXI (Dermoscopy EXplainable Intelligence) can help dermatologists decide whether a lesion may be melanoma, a serious type of skin cancer. DEXI uses artificial intelligence, or AI, which means computer technology that looks for patterns in images and information. DEXI works within a software program called the DermaGraphix Visualizer, which displays and organizes skin and lesion images. The goal of this study is to see whether DEXI can help doctors find melan...